356 related articles for article (PubMed ID: 19553814)
1. Role of PET in gynecologic malignancy.
Grigsby PW
Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
[TBL] [Abstract][Full Text] [Related]
2. Gynecologic cancers.
Blair AR; Casas CM
Prim Care; 2009 Mar; 36(1):115-30, ix. PubMed ID: 19231605
[TBL] [Abstract][Full Text] [Related]
3. PET/CT in gynecologic cancer: present applications and future prospects--a clinician's perspective.
Amit A; Schink J; Reiss A; Lowenstein L
Obstet Gynecol Clin North Am; 2011 Mar; 38(1):1-21, vii. PubMed ID: 21419325
[TBL] [Abstract][Full Text] [Related]
4. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
Schwarz JK; Grigsby PW; Dehdashti F; Delbeke D
J Nucl Med; 2009 May; 50 Suppl 1():64S-73S. PubMed ID: 19380409
[TBL] [Abstract][Full Text] [Related]
5. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
Hall KL; Dewar MA; Perchalski J
Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET Assessment of Other Gynecologic Cancers.
Faria S; Devine C; Viswanathan C; Javadi S; Korivi BR; Bhosale PR
PET Clin; 2018 Apr; 13(2):203-223. PubMed ID: 29482750
[TBL] [Abstract][Full Text] [Related]
7. Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system.
Petru E; Lück HJ; Stuart G; Gaffney D; Millan D; Vergote I;
Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):69-74. PubMed ID: 19195765
[TBL] [Abstract][Full Text] [Related]
8. Gynecologic malignancies.
Whitcomb BP
Surg Clin North Am; 2008 Apr; 88(2):301-17, vi. PubMed ID: 18381115
[TBL] [Abstract][Full Text] [Related]
9. Role of the primary physician in the detection and treatment of gynecologic cancer.
Fuller AF
Prim Care; 1981 Mar; 8(1):111-29. PubMed ID: 6911754
[TBL] [Abstract][Full Text] [Related]
10. Knowledge of tumor markers and the psychological consequences of tumor marker sampling in patients with gynecologic cancers.
Mayerhofer K; Bodner K; Aktas C; Schindl M; Kaider A; Leodolter S; Joura EA; Kainz C
Anticancer Res; 2000; 20(2B):1281-4. PubMed ID: 10810435
[TBL] [Abstract][Full Text] [Related]
11. [Value of plasma ribonuclease as a marker for gynecologic tumors and breast tumors].
Kraus H; Deinert S
Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):20-2. PubMed ID: 3956957
[TBL] [Abstract][Full Text] [Related]
12. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
Salani R; Backes FJ; Fung MF; Holschneider CH; Parker LP; Bristow RE; Goff BA
Am J Obstet Gynecol; 2011 Jun; 204(6):466-78. PubMed ID: 21752752
[TBL] [Abstract][Full Text] [Related]
13. [Value of colposcopy in diagnosing recurrent gynecologic malignancies].
Zhang WH
Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):438-40. PubMed ID: 2076640
[TBL] [Abstract][Full Text] [Related]
14. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
Schwartz PE; Cracchiolo BM; Cole LA
Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging in the management of gynecologic malignancies.
Lai CH; Lin G; Yen TC; Liu FY
Gynecol Oncol; 2014 Oct; 135(1):156-62. PubMed ID: 25065896
[TBL] [Abstract][Full Text] [Related]
17. The Role of PET Imaging in Gynecologic Radiation Oncology.
Rao YJ; Grigsby PW
PET Clin; 2018 Apr; 13(2):225-237. PubMed ID: 29482751
[TBL] [Abstract][Full Text] [Related]
18. Cytology of voided urine in the diagnosis of gynecologic malignancy.
Smith P; Crozier EH
Obstet Gynecol; 1973 Mar; 41(3):440-2. PubMed ID: 4688260
[No Abstract] [Full Text] [Related]
19. Gynecologic malignancies in older women.
Mirhashemi R; Nieves-Neira W; Averette HE
Oncology (Williston Park); 2001 May; 15(5):580-6; discussion 592-4, 597-8. PubMed ID: 11396354
[TBL] [Abstract][Full Text] [Related]
20. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
